Country Performance
Access to SMA medicines
Roche - Evrysdi
goodto improvenot goodearly access programnot authorised or not availablemissing data
Stay updated!
Newsletter sign up
Keep up-to-date with the OdySMA project. Sign up to receive our digital newsletter
An SMA Europe initiative, supported by:
OdySMA is a participatory advocacy tool. Therefore SMA Europe cannot warrant the completeness, reliability, or absolute accuracy of the data shared on OdySMA, as there may be changes that our members and supporters do not immediately inform us of. Should you identify inaccuracies or omissions, please contact laura.gumbert@sma-europe.eu us and let us know. We count on you!